 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 6: June 2004
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE; ORAL
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
>A> AB ANABOLIC LABS 325MG;50MG;40MG;30MG N76560 001 Jun 10, 2004 Jun NEWA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> + MIKART 300MG;10MG N40556 001 Jun 23, 2004 Jun NEWA
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
OXYCODONE AND ACETAMINOPHEN
>A> AA MALLINCKRODT 325MG;7.5MG N40545 001 Jun 30, 2004 Jun NEWA
>A> AA 325MG;10MG N40545 002 Jun 30, 2004 Jun NEWA
>A> AA 500MG;7.5MG N40550 001 Jun 30, 2004 Jun NEWA
>A> AA 650MG;10MG N40550 002 Jun 30, 2004 Jun NEWA
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET; ORAL
DARVOCET A500
>D> AAIPHARMA 500MG;100MG N76429 001 Sep 10, 2003 Jun CFTG
>A> AB 500MG;100MG N76429 001 Sep 10, 2003 Jun CFTG
>A> PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A> AB VINTAGE PHARMS 500MG;100MG N76750 001 Jun 28, 2004 Jun NEWA
ADENOSINE
INJECTABLE; INJECTION
ADENOCARD
>D> + FUJISAWA 3MG/ML N19937 002 Oct 30, 1989 Jun CFTG
>A> AP + 3MG/ML N19937 002 Oct 30, 1989 Jun CFTG
>A> ADENOSINE
>A> AP BAXTER HLTHCARE 3MG/ML N76501 001 Jun 16, 2004 Jun NEWA
>A> AP 3MG/ML N76500 001 Jun 16, 2004 Jun NEWA
>A> AP BEDFORD 3MG/ML N76404 001 Jun 16, 2004 Jun NEWA
>A> AP SICOR PHARMS 3MG/ML N76564 001 Jun 16, 2004 Jun NEWA
>D> ALATROFLOXACIN MESYLATE
>D> INJECTABLE; INJECTION
>D> TROVAN PRESERVATIVE FREE
>D> PFIZER EQ 200MG BASE/VIAL N20760 001 Dec 18, 1997 Jun DISC
>A> @ EQ 200MG BASE/VIAL N20760 001 Dec 18, 1997 Jun DISC
>D> + EQ 300MG BASE/VIAL N20760 002 Dec 18, 1997 Jun DISC
>A> @ EQ 300MG BASE/VIAL N20760 002 Dec 18, 1997 Jun DISC
ALBUMIN IODINATED I-125 SERUM
INJECTABLE; INJECTION
ALBUMOTOPE 125 I
>D> @ ISO TEX 5-50uCi/AMP N17836 001 Jun CMFD
JEANATOPE
>A> ISO TEX 100UCI/10ML(10UCI/ML) N17836 003 Jun 08, 2004 Jun NEWA
>A> 500uCi/0.5ML N17836 001 Jun CMFD
>A> + 1,000uCi/ML N17836 002 Jun CMFD
>D> RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125
>D> MALLINCKRODT 10uCi/ML N17844 001 Jun DISC
>A> @ 10uCi/ML N17844 001 Jun DISC
ALBUTEROL SULFATE
SOLUTION; INHALATION
ACCUNEB
>D> + DEY EQ 0.042% BASE N20949 001 Apr 30, 2001 Jun CFTG
>A> AN + EQ 0.042% BASE N20949 001 Apr 30, 2001 Jun CFTG
ALBUTEROL SULFATE
>D> AN BAUSCH AND LOMB EQ 0.083% BASE N75358 001 Mar 29, 2000 Jun CRLD
>A> AN + EQ 0.083% BASE N75358 001 Mar 29, 2000 Jun CRLD
>D> AN EQ 0.5% BASE N75050 001 Jun 18, 1998 Jun CRLD
>A> AN + EQ 0.5% BASE N75050 001 Jun 18, 1998 Jun CRLD
>A> AN NEPHRON EQ 0.042% BASE N76355 001 Jun 28, 2004 Jun NEWA
>D> PROVENTIL
>D> AN + SCHERING EQ 0.083% BASE N19243 002 Jan 14, 1987 Jun DISC
>A> @ EQ 0.083% BASE N19243 002 Jan 14, 1987 Jun DISC
>D> AN + EQ 0.5% BASE N19243 001 Jan 14, 1987 Jun DISC
>A> @ EQ 0.5% BASE N19243 001 Jan 14, 1987 Jun DISC
ALLOPURINOL SODIUM
INJECTABLE; INJECTION
ALOPRIM
>D> + DSM PHARMS EQ 500MG BASE/VIAL N20298 001 May 17, 1996 Jun CAHN
>A> + NABI EQ 500MG BASE/VIAL N20298 001 May 17, 1996 Jun CAHN
AMMONIUM LACTATE
LOTION; TOPICAL
AMMONIUM LACTATE
>A> AB CLAY PARK EQ 12% BASE N75570 001 Jun 23, 2004 Jun NEWA
AMPICILLIN SODIUM
INJECTABLE; INJECTION
AMPICILLIN SODIUM
>D> AP + APOTHECON EQ 125MG BASE/VIAL N61395 001 Jun CAHN
>D> AP + EQ 250MG BASE/VIAL N61395 002 Jun CAHN
>D> AP + EQ 500MG BASE/VIAL N61395 003 Jun CAHN
>D> AP + EQ 1GM BASE/VIAL N61395 004 Jun CAHN
>D> AP + EQ 2GM BASE/VIAL N61395 005 Jun CAHN
>D> AP + EQ 10GM BASE/VIAL N61395 006 Jun CAHN
>A> AP + SANDOZ EQ 125MG BASE/VIAL N61395 001 Jun CAHN
>A> AP + EQ 250MG BASE/VIAL N61395 002 Jun CAHN
>A> AP + EQ 500MG BASE/VIAL N61395 003 Jun CAHN
>A> AP + EQ 1GM BASE/VIAL N61395 004 Jun CAHN
>A> AP + EQ 2GM BASE/VIAL N61395 005 Jun CAHN
>A> AP + EQ 10GM BASE/VIAL N61395 006 Jun CAHN
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
>D> DARVON COMPOUND
>D> + AAIPHARMA LLC 389MG;32.4MG;32MG N10996 006 Mar 08, 1983 Jun DISC
>A> @ 389MG;32.4MG;32MG N10996 006 Mar 08, 1983 Jun DISC
BECLOMETHASONE DIPROPIONATE
AEROSOL, METERED; INHALATION
VANCERIL
>D> BN + SCHERING 0.042MG/INH N17573 001 Jun CTEC
>A> + 0.042MG/INH N17573 001 Jun CTEC
>D> VANCERIL DOUBLE STRENGTH
>D> + SCHERING 0.084MG/INH N20486 001 Dec 24, 1996 Jun DISC
>A> @ 0.084MG/INH N20486 001 Dec 24, 1996 Jun DISC
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
SPRAY, METERED; NASAL
BECONASE AQ
>D> BN + GLAXOSMITHKLINE EQ 0.042MG DIPROP/SPRAY N19389 001 Jul 27, 1987 Jun CTEC
>A> + EQ 0.042MG DIPROP/SPRAY N19389 001 Jul 27, 1987 Jun CTEC
>D> VANCENASE AQ
>D> BN + SCHERING EQ 0.042MG DIPROP/SPRAY N19589 001 Dec 23, 1987 Jun DISC
>A> @ EQ 0.042MG DIPROP/SPRAY N19589 001 Dec 23, 1987 Jun DISC
BETHANECHOL CHLORIDE
INJECTABLE; INJECTION
URECHOLINE
>A> @ ODYSSEY PHARMS 5MG/ML N06536 001 Jun CAHN
>D> @ PLIVA 5MG/ML N06536 001 Jun CAHN
TABLET; ORAL
URECHOLINE
>A> @ ODYSSEY PHARMS 5MG N06536 003 Jun CAHN
>A> @ ODYSSEY PHARMS 10MG N06536 002 Jun CAHN
>A> @ 25MG N06536 004 Jun CAHN
>A> @ 50MG N06536 005 Jun CAHN
>D> @ PLIVA 5MG N06536 003 Jun CAHN
>D> @ 10MG N06536 002 Jun CAHN
>D> @ 25MG N06536 004 Jun CAHN
>D> @ 50MG N06536 005 Jun CAHN
BRETYLIUM TOSYLATE
INJECTABLE; INJECTION
>D> BRETYLIUM TOSYLATE
>D> AP + HOSPIRA 50MG/ML N19033 001 Apr 29, 1986 Jun DISC
>A> @ 50MG/ML N19033 001 Apr 29, 1986 Jun DISC
>D> AP INTL MEDICATION 50MG/ML N70119 001 Apr 29, 1986 Jun CRLD
>A> AP + 50MG/ML N70119 001 Apr 29, 1986 Jun CRLD
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
WELLBUTRIN SR
>D> AB + GLAXOSMITHKLINE 150MG N20358 003 Oct 04, 1996 Jun CTEC
>A> AB1 + 150MG N20358 003 Oct 04, 1996 Jun CTEC
ZYBAN
>D> AB + GLAXOSMITHKLINE 150MG N20711 003 May 14, 1997 Jun CTEC
>A> AB2 + 150MG N20711 003 May 14, 1997 Jun CTEC
CARBIDOPA; LEVODOPA
TABLET, EXTENDED RELEASE; ORAL
CARBIDOPA AND LEVODOPA
>A> AB KV PHARM 50MG;200MG N76663 001 Jun 24, 2004 Jun NEWA
>A> AB TORPHARM 25MG;100MG N76212 001 Jun 16, 2004 Jun NEWA
>A> AB 50MG;200MG N76212 002 Jun 16, 2004 Jun NEWA
CARTEOLOL HYDROCHLORIDE
>D> TABLET; ORAL
>D> CARTROL
>D> ABBOTT 2.5MG N19204 001 Dec 28, 1988 Jun DISC
>A> @ 2.5MG N19204 001 Dec 28, 1988 Jun DISC
>D> + 5MG N19204 002 Dec 28, 1988 Jun DISC
>A> @ 5MG N19204 002 Dec 28, 1988 Jun DISC
CEFACLOR
TABLET, EXTENDED RELEASE; ORAL
>D> CECLOR CD
>D> AB + LILLY EQ 500MG BASE N50673 002 Jun 28, 1996 Jun DISC
>A> @ EQ 500MG BASE N50673 002 Jun 28, 1996 Jun DISC
CEFACLOR
>D> AB IVAX PHARMS EQ 500MG BASE N65057 001 Jan 05, 2001 Jun CRLD
>A> AB + EQ 500MG BASE N65057 001 Jan 05, 2001 Jun CRLD
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>D> AP MARSAM PHARMS LLC EQ 250MG BASE/VIAL N62988 001 Dec 29, 1989 Jun DISC
>A> @ EQ 250MG BASE/VIAL N62988 001 Dec 29, 1989 Jun DISC
>D> AP EQ 500MG BASE/VIAL N62988 002 Dec 29, 1989 Jun DISC
>A> @ EQ 500MG BASE/VIAL N62988 002 Dec 29, 1989 Jun DISC
>D> AP EQ 1GM BASE/VIAL N62988 003 Dec 29, 1989 Jun DISC
>A> @ EQ 1GM BASE/VIAL N62988 003 Dec 29, 1989 Jun DISC
>D> AP EQ 5GM BASE/VIAL N62989 001 Dec 29, 1989 Jun DISC
>A> @ EQ 5GM BASE/VIAL N62989 001 Dec 29, 1989 Jun DISC
>D> AP EQ 10GM BASE/VIAL N62989 002 Dec 29, 1989 Jun DISC
>A> @ EQ 10GM BASE/VIAL N62989 002 Dec 29, 1989 Jun DISC
>D> AP EQ 20GM BASE/VIAL N62989 003 Dec 29, 1989 Jun DISC
>A> @ EQ 20GM BASE/VIAL N62989 003 Dec 29, 1989 Jun DISC
>D> KEFZOL
>D> AP + LILLY EQ 250MG BASE/VIAL N61773 001 Jun DISC
>A> @ EQ 250MG BASE/VIAL N61773 001 Jun DISC
>D> AP EQ 500MG BASE/VIAL N61773 002 Jun DISC
>A> @ EQ 500MG BASE/VIAL N61773 002 Jun DISC
>D> AP LILLY EQ 1GM BASE/VIAL N61773 003 Jun DISC
>A> @ EQ 1GM BASE/VIAL N61773 003 Jun DISC
>D> AP EQ 10GM BASE/VIAL N61773 004 Jun DISC
>A> @ EQ 10GM BASE/VIAL N61773 004 Jun DISC
>D> AP + EQ 20GM BASE/VIAL N61773 005 Sep 08, 1987 Jun DISC
>A> @ EQ 20GM BASE/VIAL N61773 005 Sep 08, 1987 Jun DISC
CEFUROXIME SODIUM
INJECTABLE; IM-IV
>D> KEFUROX
>D> AB LILLY EQ 750MG BASE/VIAL N62591 001 Jan 10, 1986 Jun DISC
>A> @ EQ 750MG BASE/VIAL N62591 001 Jan 10, 1986 Jun DISC
INJECTABLE; INJECTION
>D> KEFUROX
>D> AP LILLY EQ 1.5GM BASE/VIAL N62592 002 Jan 10, 1986 Jun DISC
>A> @ EQ 1.5GM BASE/VIAL N62592 002 Jan 10, 1986 Jun DISC
>D> AP EQ 1.5GM BASE/VIAL N62591 002 Jan 10, 1986 Jun DISC
>A> @ EQ 1.5GM BASE/VIAL N62591 002 Jan 10, 1986 Jun DISC
>D> AP EQ 7.5GM BASE/VIAL N62591 003 Dec 17, 1987 Jun DISC
>A> @ EQ 7.5GM BASE/VIAL N62591 003 Dec 17, 1987 Jun DISC
INJECTABLE; INTRAVENOUS
>D> KEFUROX
>D> AP LILLY EQ 750MG BASE/VIAL N62592 001 Jan 10, 1986 Jun DISC
>A> @ EQ 750MG BASE/VIAL N62592 001 Jan 10, 1986 Jun DISC
CEPHALEXIN
CAPSULE; ORAL
KEFLEX
>A> AB ADVANCIS PHARM EQ 250MG BASE N50405 002 Jun CAHN
>A> AB + EQ 500MG BASE N50405 003 Jun CAHN
>D> AB LILLY EQ 250MG BASE N50405 002 Jun CAHN
>D> AB + EQ 500MG BASE N50405 003 Jun CAHN
FOR SUSPENSION; ORAL
KEFLEX
>A> @ ADVANCIS PHARM EQ 100MG BASE/ML N50406 003 Jun CAHN
>A> @ EQ 125MG BASE/5ML N50406 001 Jun CAHN
>A> @ EQ 250MG BASE/5ML N50406 002 Jun CAHN
>D> @ LILLY EQ 100MG BASE/ML N50406 003 Jun CAHN
>D> @ EQ 125MG BASE/5ML N50406 001 Jun CAHN
>D> @ EQ 250MG BASE/5ML N50406 002 Jun CAHN
TABLET; ORAL
>D> KEFLET
>D> AB LILLY EQ 250MG BASE N50440 003 Feb 26, 1987 Jun DISC
>A> @ EQ 250MG BASE N50440 003 Feb 26, 1987 Jun DISC
CEVIMELINE HYDROCHLORIDE
CAPSULE; ORAL
EVOXAC
>D> + DAIICHI EQ 30MG BASE N20989 002 Jan 11, 2000 Jun CAHN
>A> + EQ 30MG BASE N20989 002 Jan 11, 2000 Jun CAHN
CHLORDIAZEPOXIDE HYDROCHLORIDE
>D> INJECTABLE; INJECTION
>D> LIBRIUM
>D> + VALEANT PHARM INTL 100MG/AMP N12301 001 Jun DISC
>A> @ 100MG/AMP N12301 001 Jun DISC
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
NESACAINE
>D> ASTRAZENECA 2% N09435 002 Jun CTEC
>A> AP 2% N09435 002 Jun CTEC
>A> CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
>A> SUSPENSION, EXTENDED RELEASE; ORAL
>A> CODEPREX
>A> + CELLTECH PHARMS EQ 4MG MALEATE/5ML;EQ 20MG N21369 001 Jun 21, 2004 Jun NEWA
CIPROFLOXACIN HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
CIPROFLOXACIN
>A> AT BAUSCH AND LOMB EQ 0.3% BASE N76754 001 Jun 09, 2004 Jun NEWA
>A> AT NOVEX EQ 0.3% BASE N75928 001 Jun 09, 2004 Jun NEWA
TABLET; ORAL
CIPRO
>D> BAYER PHARMS EQ 100MG BASE N19537 001 Apr 08, 1996 Jun CFTG
>A> AB EQ 100MG BASE N19537 001 Apr 08, 1996 Jun CFTG
>D> EQ 250MG BASE N19537 002 Oct 22, 1987 Jun CFTG
>A> AB EQ 250MG BASE N19537 002 Oct 22, 1987 Jun CFTG
>D> EQ 500MG BASE N19537 003 Oct 22, 1987 Jun CFTG
>A> AB EQ 500MG BASE N19537 003 Oct 22, 1987 Jun CFTG
>D> + EQ 750MG BASE N19537 004 Oct 22, 1987 Jun CFTG
>A> AB + EQ 750MG BASE N19537 004 Oct 22, 1987 Jun CFTG
>A> CIPROFLOXACIN
>A> AB BARR EQ 250MG BASE N74124 001 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N74124 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N74124 003 Jun 09, 2004 Jun NEWA
>A> AB COBALT EQ 250MG BASE N76794 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76794 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76794 004 Jun 09, 2004 Jun NEWA
>A> AB DR REDDYS LABS LTD EQ 100MG BASE N75593 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 250MG BASE N75593 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N75593 004 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N75593 001 Jun 09, 2004 Jun NEWA
>A> AB EON EQ 250MG BASE N76593 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76593 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76593 004 Jun 09, 2004 Jun NEWA
>A> AB GENPHARM EQ 250MG BASE N75817 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N75817 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N75817 004 Jun 09, 2004 Jun NEWA
>A> AB HIKMA EQ 250MG BASE N76558 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76558 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76558 004 Jun 09, 2004 Jun NEWA
>A> AB IVAX PHARMS EQ 250MG BASE N76089 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76089 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76089 004 Jun 09, 2004 Jun NEWA
>A> AB MARTEC EQ 250MG BASE N76138 001 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76138 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76138 003 Jun 09, 2004 Jun NEWA
>A> AB MYLAN EQ 250MG BASE N75685 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N75685 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N75685 001 Jun 09, 2004 Jun NEWA
>A> AB RANBAXY EQ 250MG BASE N75747 001 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N75747 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N75747 003 Jun 09, 2004 Jun NEWA
>A> AB SANDOZ EQ 250MG BASE N75939 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N75939 003 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N75939 004 Jun 09, 2004 Jun NEWA
>A> AB TEVA EQ 250MG BASE N76136 001 Jun 09, 2004 Jun NEWA
>A> AB EQ 500MG BASE N76136 002 Jun 09, 2004 Jun NEWA
>A> AB EQ 750MG BASE N76136 003 Jun 09, 2004 Jun NEWA
CLARITHROMYCIN
TABLET, EXTENDED RELEASE; ORAL
BIAXIN XL
>D> + ABBOTT 500MG N50775 001 Mar 03, 2000 Jun CFTG
>A> AB + 500MG N50775 001 Mar 03, 2000 Jun CFTG
>A> CLARITHROMYCIN
>A> AB ANDRX PHARMS 500MG N65145 001 Jun 24, 2004 Jun NEWA
CLONIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
DURACLON
>D> + AAIPHARMA 0.1MG/ML N20615 001 Oct 02, 1996 Jun CRLD
>A> 0.1MG/ML N20615 001 Oct 02, 1996 Jun CRLD
>A> + 0.5MG/ML N20615 002 Apr 27, 1999 Jun NEWA
>D> DESERPIDINE; METHYCLOTHIAZIDE
>D> TABLET; ORAL
>D> ENDURONYL
>D> ABBOTT 0.25MG;5MG N12775 001 Jun DISC
>A> @ 0.25MG;5MG N12775 001 Jun DISC
>D> ENDURONYL FORTE
>D> + ABBOTT 0.5MG;5MG N12775 002 Jun DISC
>A> @ 0.5MG;5MG N12775 002 Jun DISC
DESOXIMETASONE
CREAM; TOPICAL
TOPICORT
>D> AB + MEDICIS 0.25% N17856 001 Jun CAHN
>A> AB + TARO PHARMS NORTH 0.25% N17856 001 Jun CAHN
TOPICORT LP
>D> AB + MEDICIS 0.05% N18309 001 Jun CAHN
>A> AB + TARO PHARMS NORTH 0.05% N18309 001 Jun CAHN
GEL; TOPICAL
TOPICORT
>D> AB + MEDICIS 0.05% N18586 001 Mar 29, 1982 Jun CAHN
>A> AB + TARO PHARMS NORTH 0.05% N18586 001 Mar 29, 1982 Jun CAHN
OINTMENT; TOPICAL
TOPICORT
>D> @ MEDICIS 0.05% N18594 001 Jan 17, 1985 Jun CAHN
>D> AB + 0.25% N18763 001 Sep 30, 1983 Jun CAHN
>A> @ TARO PHARMS NORTH 0.05% N18594 001 Jan 17, 1985 Jun CAHN
>A> AB + 0.25% N18763 001 Sep 30, 1983 Jun CAHN
DIDANOSINE
FOR SOLUTION; ORAL
VIDEX
>D> BRISTOL MYERS 10MG/ML N20156 001 Oct 09, 1991 Jun CRLD
>A> + 10MG/ML N20156 001 Oct 09, 1991 Jun CRLD
>D> 100MG/PACKET N20155 003 Oct 09, 1991 Jun DISC
>A> @ 100MG/PACKET N20155 003 Oct 09, 1991 Jun DISC
>D> 167MG/PACKET N20155 004 Oct 09, 1991 Jun DISC
>A> @ 167MG/PACKET N20155 004 Oct 09, 1991 Jun DISC
>D> + 250MG/PACKET N20155 005 Oct 09, 1991 Jun DISC
>A> @ 250MG/PACKET N20155 005 Oct 09, 1991 Jun DISC
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
>D> CARDIZEM SR
>D> AB1 + AVENTIS PHARMS 60MG N19471 001 Jan 23, 1989 Jun DISC
>A> @ 60MG N19471 001 Jan 23, 1989 Jun DISC
>D> AB1 + 90MG N19471 002 Jan 23, 1989 Jun DISC
>A> @ 90MG N19471 002 Jan 23, 1989 Jun DISC
>D> AB1 + 120MG N19471 003 Jan 23, 1989 Jun DISC
>A> @ 120MG N19471 003 Jan 23, 1989 Jun DISC
DILTIAZEM HCL
>D> AB1 BIOVAIL 60MG N74845 001 Sep 15, 1999 Jun DISC
>A> @ 60MG N74845 001 Sep 15, 1999 Jun DISC
>D> AB1 90MG N74845 002 Sep 15, 1999 Jun DISC
>A> @ 90MG N74845 002 Sep 15, 1999 Jun DISC
>D> AB1 120MG N74845 003 Sep 15, 1999 Jun DISC
>A> @ 120MG N74845 003 Sep 15, 1999 Jun DISC
>D> AB1 MYLAN 60MG N74910 001 May 02, 1997 Jun CRLD
>A> + 60MG N74910 001 May 02, 1997 Jun CRLD
>D> AB1 90MG N74910 002 May 02, 1997 Jun CRLD
>A> + 90MG N74910 002 May 02, 1997 Jun CRLD
>D> AB1 120MG N74910 003 May 02, 1997 Jun CRLD
>A> + 120MG N74910 003 May 02, 1997 Jun CRLD
>D> AB1 TEVA 60MG N74079 001 Nov 30, 1993 Jun DISC
>A> @ 60MG N74079 001 Nov 30, 1993 Jun DISC
>D> AB1 90MG N74079 002 Nov 30, 1993 Jun DISC
>A> @ 90MG N74079 002 Nov 30, 1993 Jun DISC
>D> AB1 120MG N74079 003 Nov 30, 1993 Jun DISC
>A> @ 120MG N74079 003 Nov 30, 1993 Jun DISC
DIMENHYDRINATE
INJECTABLE; INJECTION
>A> DIMENHYDRINATE
>A> AP AM PHARM 50MG/ML N40519 001 Jun 23, 2004 Jun NEWA
>D> + STERIS 50MG/ML N80615 001 Jun CFTG
>A> AP + 50MG/ML N80615 001 Jun CFTG
DISULFIRAM
TABLET; ORAL
ANTABUSE
>A> @ ODYSSEY PHARMS 250MG N07883 003 Jun CAHN
>A> @ 500MG N07883 002 Jun CAHN
>D> @ PLIVA 250MG N07883 003 Jun CAHN
>D> @ 500MG N07883 002 Jun CAHN
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> DOBUTREX
>D> AP + LILLY EQ 12.5MG BASE/ML N17820 002 Jun DISC
>A> @ EQ 12.5MG BASE/ML N17820 002 Jun DISC
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> DOPAMINE HCL IN DEXTROSE 5%
>D> AP + HOSPIRA 1.6MG/ML N20542 001 Aug 30, 1995 Jun DISC
>A> @ 1.6MG/ML N20542 001 Aug 30, 1995 Jun DISC
DOXAZOSIN MESYLATE
TABLET; ORAL
DOXAZOSIN MESYLATE
>A> AB CLONMEL HLTHCARE EQ 1MG BASE N76161 001 Jun 10, 2004 Jun NEWA
>A> AB EQ 2MG BASE N76161 002 Jun 10, 2004 Jun NEWA
>A> AB EQ 4MG BASE N76161 003 Jun 10, 2004 Jun NEWA
>A> AB EQ 8MG BASE N76161 004 Jun 10, 2004 Jun NEWA
DOXORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
>D> ADRIAMYCIN RDF
>D> AP + PHARMACIA AND 10MG/VIAL N50467 001 Jun DISC
>A> @ 10MG/VIAL N50467 001 Jun DISC
>D> AP + 20MG/VIAL N50467 003 May 20, 1985 Jun DISC
>A> @ 20MG/VIAL N50467 003 May 20, 1985 Jun DISC
>D> AP + 50MG/VIAL N50467 002 Jun DISC
>A> @ 50MG/VIAL N50467 002 Jun DISC
ECONAZOLE NITRATE
CREAM; TOPICAL
ECONAZOLE NITRATE
>A> AB CLAY PARK 1% N76479 001 Jun 23, 2004 Jun NEWA
EFAVIRENZ
TABLET; ORAL
SUSTIVA
>D> BRISTOL MYERS 300MG N21360 001 Feb 01, 2002 Jun DISC
>A> @ 300MG N21360 001 Feb 01, 2002 Jun DISC
ERYTHROMYCIN
SOLUTION; TOPICAL
>D> C-SOLVE-2
>D> AT BIOGLAN PHARMA 2% N62468 001 Jul 03, 1985 Jun DISC
>A> @ 2% N62468 001 Jul 03, 1985 Jun DISC
ESTRADIOL
FILM, EXTENDED RELEASE; TRANSDERMAL
>A> MENOSTAR
>A> + BERLEX LABS 0.014MG/24HR N21674 001 Jun 08, 2004 Jun NEWA
ETHINYL ESTRADIOL; NORGESTIMATE
TABLET; ORAL-28
ORTHO TRI-CYCLEN LO
>D> + JOHNSON AND 0.025MG,0.025MG,0.25MG;0.18MG,0.25 N21241 001 Aug 22, 2002 Jun CAHN
MG,0.215MG
>A> + ORTHO MCNEIL PHARM 0.025MG,0.025MG,0.25MG;0.18MG,0.25 N21241 001 Aug 22, 2002 Jun CAHN
MG,0.215MG
ETIDRONATE DISODIUM
>D> INJECTABLE; INJECTION
>D> DIDRONEL
>D> + MGI PHARMA INC 50MG/ML N19545 001 Apr 20, 1987 Jun DISC
>A> @ 50MG/ML N19545 001 Apr 20, 1987 Jun DISC
FLUNISOLIDE
SPRAY, METERED; NASAL
FLUNISOLIDE
>D> AB BAUSCH AND LOMB 0.025MG/SPRAY N74805 001 Feb 20, 2002 Jun CRLD
>A> + 0.025MG/SPRAY N74805 001 Feb 20, 2002 Jun CRLD
NASALIDE
>D> AB + IVAX RES 0.025MG/SPRAY N18148 001 Jun DISC
>A> @ 0.025MG/SPRAY N18148 001 Jun DISC
FLUOCINONIDE
CREAM; TOPICAL
FLUOCINONIDE EMULSIFIED BASE
>A> AB2 ALTANA 0.05% N76586 001 Jun 23, 2004 Jun NEWA
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
>D> PERMITIL
>D> AA + SCHERING 5MG/ML N16008 001 Jun DISC
>A> @ 5MG/ML N16008 001 Jun DISC
FOLLITROPIN ALFA/BETA
INJECTABLE; IM-SC
FOLLISTIM
>D> BX ORGANON USA INC 75 IU/VIAL N20582 001 Sep 29, 1997 Jun CTEC
>A> + 75 IU/VIAL N20582 001 Sep 29, 1997 Jun CTEC
>D> BX 150 IU/VIAL N20582 002 Sep 29, 1997 Jun CTEC
>A> + 150 IU/VIAL N20582 002 Sep 29, 1997 Jun CTEC
INJECTABLE; SUBCUTANEOUS
GONAL-F
>D> SERONO INC 75 IU/VIAL N21765 002 Mar 25, 2004 Jun CRLD
>A> + 75 IU/VIAL N21765 002 Mar 25, 2004 Jun CRLD
>D> BX 75 IU/VIAL N20378 001 Sep 29, 1997 Jun DISC
>A> @ 75 IU/VIAL N20378 001 Sep 29, 1997 Jun DISC
>D> BX 150 IU/VIAL N20378 002 Sep 29, 1997 Jun DISC
>A> @ 150 IU/VIAL N20378 002 Sep 29, 1997 Jun DISC
GANIRELIX ACETATE
INJECTABLE; INJECTION
>D> ANTAGON
>D> + ORGANON USA INC EQ 250UGM BASE/0.5ML N21057 001 Jul 29, 1999 Jun CTNA
>A> GANIRELIX ACETATE INJECTION
>A> + ORGANON USA INC EQ 250UGM BASE/0.5ML N21057 001 Jul 29, 1999 Jun CTNA
>A> GLUTAMINE
>A> FOR SOLUTION; ORAL
>A> NUTRESTORE
>A> + NUTRITIONAL 5GM/PACKET N21677 001 Jun 10, 2004 Jun NEWA
>D> GONADORELIN HYDROCHLORIDE
>D> INJECTABLE; INJECTION
>D> FACTREL
>D> + BAXTER HLTHCARE EQ 0.1MG BASE/VIAL N18123 001 Sep 30, 1982 Jun DISC
>A> @ EQ 0.1MG BASE/VIAL N18123 001 Sep 30, 1982 Jun DISC
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET; ORAL
>D> FULVICIN P/G
>D> AB SCHERING 125MG N61996 001 Jun DISC
>A> @ 125MG N61996 001 Jun DISC
>D> AB + 250MG N61996 002 Jun DISC
>A> @ SCHERING 250MG N61996 002 Jun DISC
>D> FULVICIN P/G 165
>D> AB SCHERING 165MG N61996 003 Apr 06, 1982 Jun DISC
>A> @ 165MG N61996 003 Apr 06, 1982 Jun DISC
>D> FULVICIN P/G 330
>D> AB + SCHERING 330MG N61996 004 Apr 06, 1982 Jun DISC
>A> @ 330MG N61996 004 Apr 06, 1982 Jun DISC
GRIS-PEG
>D> AB PEDINOL 250MG N50475 002 Jun CRLD
>A> + 250MG N50475 002 Jun CRLD
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN SODIUM
>D> AP LILLY 10,000 UNITS/ML N05521 002 Jun DISC
>A> @ 10,000 UNITS/ML N05521 002 Jun DISC
>D> INSULIN GLULISINE RECOMBINANT
>D> INJECTABLE; SUBCUTANEOUS
>D> APIDRA
>D> + AVENTIS PHARMS 100 UNITS/ML N21629 001 Apr 16, 2004 Jun DISC
>A> @ 100 UNITS/ML N21629 001 Apr 16, 2004 Jun DISC
IODIXANOL
INJECTABLE; INJECTION
VISIPAQUE 270
>D> @ GE HEALTHCARE 55% N20808 001 Aug 29, 1997 Jun CMFD
>A> 55% N20808 001 Aug 29, 1997 Jun CMFD
VISIPAQUE 320
>D> @ GE HEALTHCARE 65.2% N20808 002 Aug 29, 1997 Jun CMFD
>A> 65.2% N20808 002 Aug 29, 1997 Jun CMFD
>D> IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM
>D> INJECTABLE; INJECTION
>D> VASCORAY
>D> + MALLINCKRODT 52%;26% N16783 001 Jun DISC
>A> @ 52%;26% N16783 001 Jun DISC
LEVOTHYROXINE SODIUM
TABLET; ORAL
LEVO-T
>D> BX ALARA PHARM 0.025MG N21342 001 Mar 01, 2002 Jun CTEC
>A> AB2, 0.025MG N21342 001 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.05MG N21342 002 Mar 01, 2002 Jun CTEC
>A> AB2, 0.05MG N21342 002 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.075MG N21342 003 Mar 01, 2002 Jun CTEC
>A> AB2, 0.075MG N21342 003 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.088MG N21342 004 Mar 01, 2002 Jun CTEC
>A> AB2, 0.088MG N21342 004 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.1MG N21342 005 Mar 01, 2002 Jun CTEC
>A> AB2, 0.1MG N21342 005 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.112MG N21342 006 Mar 01, 2002 Jun CTEC
>A> AB2, 0.112MG N21342 006 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.125MG N21342 007 Mar 01, 2002 Jun CTEC
>A> AB2, 0.125MG N21342 007 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.137MG N21342 012 Dec 08, 2003 Jun CTEC
>A> AB2, 0.137MG N21342 012 Dec 08, 2003 Jun CTEC
>A> AB3
>D> BX 0.15MG N21342 008 Mar 01, 2002 Jun CTEC
>A> AB2, 0.15MG N21342 008 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.175MG N21342 009 Mar 01, 2002 Jun CTEC
>A> AB2, 0.175MG N21342 009 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX 0.2MG N21342 010 Mar 01, 2002 Jun CTEC
>A> AB2, 0.2MG N21342 010 Mar 01, 2002 Jun CTEC
>A> AB3
>D> BX + 0.3MG N21342 011 Mar 01, 2002 Jun CTEC
>A> AB2,+ 0.3MG N21342 011 Mar 01, 2002 Jun CTEC
>A> AB3
LEVOTHYROXINE SODIUM
>D> AB MYLAN 0.025MG N76187 001 Jun 05, 2002 Jun CTEC
>A> AB1, 0.025MG N76187 001 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.05MG N76187 002 Jun 05, 2002 Jun CTEC
>A> AB1, 0.05MG N76187 002 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.075MG N76187 003 Jun 05, 2002 Jun CTEC
>A> AB1, 0.075MG N76187 003 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.088MG N76187 004 Jun 05, 2002 Jun CTEC
>A> AB1, 0.088MG N76187 004 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.1MG N76187 005 Jun 05, 2002 Jun CTEC
>A> AB1, 0.1MG N76187 005 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.112MG N76187 006 Jun 05, 2002 Jun CTEC
>A> AB1, 0.112MG N76187 006 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.125MG N76187 007 Jun 05, 2002 Jun CTEC
>A> AB1, 0.125MG N76187 007 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.15MG N76187 008 Jun 05, 2002 Jun CTEC
>A> AB1, 0.15MG N76187 008 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.175MG N76187 009 Jun 05, 2002 Jun CTEC
>A> AB1, 0.175MG N76187 009 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.2MG N76187 010 Jun 05, 2002 Jun CTEC
>A> AB1, 0.2MG N76187 010 Jun 05, 2002 Jun CTEC
AB2,
AB3
>D> AB 0.3MG N76187 011 Jun 05, 2002 Jun CTEC
>A> AB1, 0.3MG N76187 011 Jun 05, 2002 Jun CTEC
AB2,
AB3
LEVOXYL
>D> BX JONES PHARMA 0.025MG N21301 001 May 25, 2001 Jun CTEC
>A> AB1, 0.025MG N21301 001 May 25, 2001 Jun CTEC
AB3
>D> BX 0.05MG N21301 002 May 25, 2001 Jun CTEC
>A> AB1, 0.05MG N21301 002 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.075MG N21301 003 May 25, 2001 Jun CTEC
>A> AB1, 0.075MG N21301 003 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.088MG N21301 004 May 25, 2001 Jun CTEC
>A> AB1, 0.088MG N21301 004 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.1MG N21301 005 May 25, 2001 Jun CTEC
>A> AB1, 0.1MG N21301 005 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.112MG N21301 006 May 25, 2001 Jun CTEC
>A> AB1, 0.112MG N21301 006 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.125MG N21301 007 May 25, 2001 Jun CTEC
>A> AB1, 0.125MG N21301 007 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.137MG N21301 008 May 25, 2001 Jun CTEC
>A> AB1, JONES PHARMA 0.137MG N21301 008 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.15MG N21301 009 May 25, 2001 Jun CTEC
>A> AB1, 0.15MG N21301 009 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.175MG N21301 010 May 25, 2001 Jun CTEC
>A> AB1, 0.175MG N21301 010 May 25, 2001 Jun CTEC
>A> AB3
>D> BX 0.2MG N21301 011 May 25, 2001 Jun CTEC
>A> AB1, 0.2MG N21301 011 May 25, 2001 Jun CTEC
>A> AB3
>D> BX + 0.3MG N21301 012 May 25, 2001 Jun CTEC
>A> AB1,+ 0.3MG N21301 012 May 25, 2001 Jun CTEC
>A> AB3
SYNTHROID
>D> BX ABBOTT 0.025MG N21402 001 Jul 24, 2002 Jun CFTG
>A> AB2 0.025MG N21402 001 Jul 24, 2002 Jun CFTG
>D> BX 0.05MG N21402 002 Jul 24, 2002 Jun CFTG
>A> AB2 0.05MG N21402 002 Jul 24, 2002 Jun CFTG
>D> BX 0.075MG N21402 003 Jul 24, 2002 Jun CFTG
>A> AB2 0.075MG N21402 003 Jul 24, 2002 Jun CFTG
>D> BX 0.088MG N21402 004 Jul 24, 2002 Jun CFTG
>A> AB2 0.088MG N21402 004 Jul 24, 2002 Jun CFTG
>D> BX 0.1MG N21402 005 Jul 24, 2002 Jun CFTG
>A> AB2 0.1MG N21402 005 Jul 24, 2002 Jun CFTG
>D> BX 0.112MG N21402 006 Jul 24, 2002 Jun CFTG
>A> AB2 0.112MG N21402 006 Jul 24, 2002 Jun CFTG
>D> BX 0.125MG N21402 007 Jul 24, 2002 Jun CFTG
>A> AB2 0.125MG N21402 007 Jul 24, 2002 Jun CFTG
>D> BX 0.137MG N21402 008 Jul 24, 2002 Jun CFTG
>A> AB2 0.137MG N21402 008 Jul 24, 2002 Jun CFTG
>D> BX 0.15MG N21402 009 Jul 24, 2002 Jun CFTG
>A> AB2 0.15MG N21402 009 Jul 24, 2002 Jun CFTG
>D> BX 0.175MG N21402 010 Jul 24, 2002 Jun CFTG
>A> AB2 0.175MG N21402 010 Jul 24, 2002 Jun CFTG
>D> BX 0.2MG N21402 012 Jul 24, 2002 Jun CFTG
>A> AB2 0.2MG N21402 012 Jul 24, 2002 Jun CFTG
>D> BX + 0.3MG N21402 011 Jul 24, 2002 Jun CFTG
>A> AB2 + 0.3MG N21402 011 Jul 24, 2002 Jun CFTG
UNITHROID
>D> AB STEVENS J 0.025MG N21210 001 Aug 21, 2000 Jun CTEC
>A> AB1, 0.025MG N21210 001 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.05MG N21210 002 Aug 21, 2000 Jun CTEC
>A> AB1, 0.05MG N21210 002 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.075MG N21210 003 Aug 21, 2000 Jun CTEC
>A> AB1, 0.075MG N21210 003 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.088MG N21210 004 Aug 21, 2000 Jun CTEC
>A> AB1, 0.088MG N21210 004 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.1MG N21210 005 Aug 21, 2000 Jun CTEC
>A> AB1, 0.1MG N21210 005 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.112MG N21210 006 Aug 21, 2000 Jun CTEC
>A> AB1, 0.112MG N21210 006 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.125MG N21210 007 Aug 21, 2000 Jun CTEC
>A> AB1, 0.125MG N21210 007 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.15MG N21210 008 Aug 21, 2000 Jun CTEC
>A> AB1, 0.15MG N21210 008 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.175MG N21210 009 Aug 21, 2000 Jun CTEC
>A> AB1, 0.175MG N21210 009 Aug 21, 2000 Jun CTEC
AB3
>D> AB 0.2MG N21210 010 Aug 21, 2000 Jun CTEC
>A> AB1, 0.2MG N21210 010 Aug 21, 2000 Jun CTEC
AB3
>D> AB + 0.3MG N21210 011 Aug 21, 2000 Jun CTEC
>A> AB1,+ STEVENS J 0.3MG N21210 011 Aug 21, 2000 Jun CTEC
AB3
LITHIUM CARBONATE
CAPSULE; ORAL
LITHIUM CARBONATE
>A> AB ABLE 150MG N76823 001 Jun 29, 2004 Jun NEWA
>A> AB 300MG N76823 002 Jun 29, 2004 Jun NEWA
>A> AB 600MG N76823 003 Jun 29, 2004 Jun NEWA
>D> + ROXANE 600MG N17812 003 Jan 28, 1987 Jun CFTG
>A> AB + 600MG N17812 003 Jan 28, 1987 Jun CFTG
MALATHION
LOTION; TOPICAL
OVIDE
>D> + MEDICIS 0.5% N18613 001 Aug 02, 1982 Jun CAHN
>A> + TARO PHARMS NORTH 0.5% N18613 001 Aug 02, 1982 Jun CAHN
MAPROTILINE HYDROCHLORIDE
TABLET; ORAL
LUDIOMIL
>D> AB NOVARTIS 25MG N17543 001 Jun DISC
>A> @ 25MG N17543 001 Jun DISC
>D> AB + 50MG N17543 002 Jun DISC
>A> @ 50MG N17543 002 Jun DISC
>D> AB 75MG N17543 003 Sep 30, 1982 Jun DISC
>A> @ 75MG N17543 003 Sep 30, 1982 Jun DISC
MAPROTILINE HCL
>D> AB MYLAN 50MG N72285 001 Oct 03, 1988 Jun CRLD
>A> AB + 50MG N72285 001 Oct 03, 1988 Jun CRLD
MELOXICAM
>A> SUSPENSION; ORAL
>A> MOBIC
>A> + BOEHRINGER 7.5MG/5ML N21530 001 Jun 01, 2004 Jun NEWA
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HCL
>A> AB ANDRX PHARMS 500MG N76172 001 Jun 16, 2004 Jun NEWA
>A> AB RANBAXY 500MG N76413 001 Jun 18, 2004 Jun NEWA
>A> AB TEVA 500MG N76269 001 Jun 18, 2004 Jun NEWA
METHYLDOPA
TABLET; ORAL
METHYLDOPA
>A> @ ACCORD HEALTH 125MG N70070 003 Oct 15, 1985 Jun CAHN
>A> AB 250MG N70084 001 Oct 15, 1985 Jun CAHN
>A> AB 500MG N70085 001 Oct 15, 1985 Jun CAHN
>D> @ CLONMEL HLTHCARE 125MG N70070 003 Oct 15, 1985 Jun CAHN
>D> AB 250MG N70084 001 Oct 15, 1985 Jun CAHN
>D> AB 500MG N70085 001 Oct 15, 1985 Jun CAHN
NAFCILLIN SODIUM
INJECTABLE; INJECTION
NAFCILLIN SODIUM
>D> + APOTHECON EQ 500MG BASE/VIAL N62527 001 Aug 02, 1984 Jun CAHN
>D> AP EQ 1GM BASE/VIAL N62527 002 Aug 02, 1984 Jun CAHN
>D> AP EQ 2GM BASE/VIAL N62527 003 Aug 02, 1984 Jun CAHN
>D> AP EQ 10GM BASE/VIAL N62527 004 Aug 02, 1984 Jun CAHN
>A> + SANDOZ EQ 500MG BASE/VIAL N62527 001 Aug 02, 1984 Jun CAHN
>A> AP EQ 1GM BASE/VIAL N62527 002 Aug 02, 1984 Jun CAHN
>A> AP EQ 2GM BASE/VIAL N62527 003 Aug 02, 1984 Jun CAHN
>A> AP EQ 10GM BASE/VIAL N62527 004 Aug 02, 1984 Jun CAHN
NAPROXEN SODIUM
TABLET, EXTENDED RELEASE; ORAL
NAPRELAN
>D> AB + ELAN PHARMA EQ 375MG BASE N20353 001 Jan 05, 1996 Jun CAHN
>D> AB + EQ 500MG BASE N20353 002 Jan 05, 1996 Jun CAHN
>D> @ ELAN PHARMA EQ 750MG BASE N20353 003 Jan 05, 1996 Jun CAHN
>A> AB + STAT TRADE EQ 375MG BASE N20353 001 Jan 05, 1996 Jun CAHN
>A> AB + EQ 500MG BASE N20353 002 Jan 05, 1996 Jun CAHN
>A> @ EQ 750MG BASE N20353 003 Jan 05, 1996 Jun CAHN
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE; ORAL
>D> AVENTYL HCL
>D> BD LILLY EQ 10MG BASE N14684 001 Jun DISC
>A> @ EQ 10MG BASE N14684 001 Jun DISC
>D> BD EQ 25MG BASE N14684 002 Jun DISC
>A> @ EQ 25MG BASE N14684 002 Jun DISC
NYSTATIN
>D> PASTILLE; ORAL
>D> MYCOSTATIN
>D> + BRISTOL MYERS 200,000 UNITS N50619 001 Apr 09, 1987 Jun DISC
>A> @ 200,000 UNITS N50619 001 Apr 09, 1987 Jun DISC
OFLOXACIN
SOLUTION/DROPS; OTIC
>D> FLOXIN
>D> + DAIICHI 0.3% N20799 001 Dec 16, 1997 Jun CTNA
>A> FLOXIN OTIC
>A> + DAIICHI 0.3% N20799 001 Dec 16, 1997 Jun CTNA
OLSALAZINE SODIUM
CAPSULE; ORAL
DIPENTUM
>A> + CELLTECH PHARMS 250MG N19715 001 Jul 31, 1990 Jun CAHN
>D> + PHARMACIA AND 250MG N19715 001 Jul 31, 1990 Jun CAHN
OMEPRAZOLE
>A> FOR SUSPENSION; ORAL
>A> ZEGERID
>A> + SANTARUS 20MG/PACKET N21636 001 Jun 15, 2004 Jun NEWA
OXACILLIN SODIUM
INJECTABLE; INJECTION
OXACILLIN SODIUM
>D> AP + APOTHECON EQ 250MG BASE/VIAL N61490 001 Jun CAHN
>D> AP + EQ 500MG BASE/VIAL N61490 002 Jun CAHN
>D> AP + EQ 1GM BASE/VIAL N61490 003 Jun CAHN
>D> AP + EQ 2GM BASE/VIAL N61490 004 Jun CAHN
>D> AP + EQ 10GM BASE/VIAL N61490 006 May 09, 1991 Jun CAHN
>A> AP + SANDOZ EQ 250MG BASE/VIAL N61490 001 Jun CAHN
>A> AP + EQ 500MG BASE/VIAL N61490 002 Jun CAHN
>A> AP + EQ 1GM BASE/VIAL N61490 003 Jun CAHN
>A> AP + EQ 2GM BASE/VIAL N61490 004 Jun CAHN
>A> AP + EQ 10GM BASE/VIAL N61490 006 May 09, 1991 Jun CAHN
OXYCODONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
OXYCONTIN
>D> AB + PURDUE PHARMA LP 80MG N20553 004 Jan 06, 1997 Jun CRLD
>A> AB 80MG N20553 004 Jan 06, 1997 Jun CRLD
TABLET; ORAL
OXYCODONE HCL
>A> AB MALLINCKRODT 15MG N76758 001 Jun 30, 2004 Jun NEWA
>A> AB 30MG N76758 002 Jun 30, 2004 Jun NEWA
PENTOSAN POLYSULFATE SODIUM
CAPSULE; ORAL
ELMIRON
>D> + JOHNSON AND 100MG N20193 001 Sep 26, 1996 Jun CAHN
>A> + ORTHO MCNEIL PHARM 100MG N20193 001 Sep 26, 1996 Jun CAHN
PROTRIPTYLINE HYDROCHLORIDE
TABLET; ORAL
VIVACTIL
>A> @ ODYSSEY PHARMS 5MG N16012 001 Jun CAHN
>A> @ 10MG N16012 002 Jun CAHN
>D> @ PLIVA 5MG N16012 001 Jun CAHN
>D> @ 10MG N16012 002 Jun CAHN
RISPERIDONE
TABLET, ORALLY DISINTEGRATING; ORAL
RISPERDAL
>A> JANSSEN PHARMA 0.5MG N21444 001 Apr 02, 2003 Jun CAHN
>A> + 1MG N21444 002 Apr 02, 2003 Jun CAHN
>A> 2MG N21444 003 Apr 02, 2003 Jun CAHN
>D> JOHNSON AND 0.5MG N21444 001 Apr 02, 2003 Jun CAHN
>D> + 1MG N21444 002 Apr 02, 2003 Jun CAHN
>D> 2MG N21444 003 Apr 02, 2003 Jun CAHN
ROCURONIUM BROMIDE
INJECTABLE; INJECTION
ZEMURON
>D> @ ORGANON USA INC 10MG/ML N20214 002 Mar 17, 1994 Jun CMFD
>A> 10MG/ML N20214 002 Mar 17, 1994 Jun CMFD
SEVELAMER HYDROCHLORIDE
>D> CAPSULE; ORAL
>D> RENAGEL
>D> + GENZYME 403MG N20926 001 Oct 30, 1998 Jun DISC
>A> @ 403MG N20926 001 Oct 30, 1998 Jun DISC
STAVUDINE
>D> CAPSULE, EXTENDED RELEASE; ORAL
>D> ZERIT XR
>D> BRISTOL MYERS 37.5MG N21453 001 Dec 31, 2002 Jun DISC
>A> @ 37.5MG N21453 001 Dec 31, 2002 Jun DISC
>D> 50MG N21453 002 Dec 31, 2002 Jun DISC
>A> @ 50MG N21453 002 Dec 31, 2002 Jun DISC
>D> 75MG N21453 003 Dec 31, 2002 Jun DISC
>A> @ 75MG N21453 003 Dec 31, 2002 Jun DISC
>D> + 100MG N21453 004 Dec 31, 2002 Jun DISC
>A> @ 100MG N21453 004 Dec 31, 2002 Jun DISC
TECHNETIUM TC-99M APCITIDE
INJECTABLE; INJECTION
ACUTECT
>A> BERLEX LABS N/A N20887 001 Sep 14, 1998 Jun CAHN
>D> DIATIDE RES LABS N/A N20887 001 Sep 14, 1998 Jun CAHN
TECHNETIUM TC-99M DEPREOTIDE
INJECTABLE; INJECTION
NEO TECT KIT
>A> + BERLEX LABS N/A N21012 001 Aug 03, 1999 Jun CAHN
>D> + DIATIDE RES LABS N/A N21012 001 Aug 03, 1999 Jun CAHN
THEOPHYLLINE
CAPSULE, EXTENDED RELEASE; ORAL
>D> AEROLATE III
>D> + FLEMING PHARMS 65MG N85075 003 Nov 24, 1986 Jun DISC
>A> @ 65MG N85075 003 Nov 24, 1986 Jun DISC
>D> AEROLATE JR
>D> BC FLEMING PHARMS 130MG N85075 002 Nov 24, 1986 Jun DISC
>A> @ 130MG N85075 002 Nov 24, 1986 Jun DISC
>D> AEROLATE SR
>D> BC FLEMING PHARMS 260MG N85075 001 Nov 24, 1986 Jun DISC
>A> @ 260MG N85075 001 Nov 24, 1986 Jun DISC
SOLUTION; ORAL
>D> AEROLATE
>D> + FLEMING PHARMS 150MG/15ML N89141 001 Dec 03, 1986 Jun DISC
>A> @ 150MG/15ML N89141 001 Dec 03, 1986 Jun DISC
TABLET, EXTENDED RELEASE; ORAL
>D> THEOLAIR-SR
>D> BC 3M 200MG N88369 001 Jul 16, 1987 Jun DISC
>A> @ 200MG N88369 001 Jul 16, 1987 Jun DISC
>D> 3M 250MG N86363 002 Jul 16, 1987 Jun DISC
>A> @ 250MG N86363 002 Jul 16, 1987 Jun DISC
>D> BC 300MG N88364 001 Jul 16, 1987 Jun DISC
>A> @ 300MG N88364 001 Jul 16, 1987 Jun DISC
>D> + 500MG N89132 001 Jul 16, 1987 Jun DISC
>A> @ 500MG N89132 001 Jul 16, 1987 Jun DISC
TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC
>A> ISTALOL
>A> + SENJU EQ 0.5% BASE N21516 001 Jun 04, 2004 Jun NEWA
>A> TIMOLOL MALEATE
>A> AT HI TECH PHARMA EQ 0.5% BASE N75163 001 Sep 10, 2002 Jun CDFR
>D> SOLUTION; OPHTHALMIC
>D> TIMOLOL MALEATE
>D> AT HI TECH PHARMA EQ 0.5% BASE N75163 001 Sep 10, 2002 Jun CDFR
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
>D> NEBCIN
>D> AP LILLY EQ 10MG BASE/ML N62707 001 Apr 29, 1987 Jun DISC
>A> @ EQ 10MG BASE/ML N62707 001 Apr 29, 1987 Jun DISC
>D> AP EQ 10MG BASE/ML N62008 004 Jun DISC
>A> @ EQ 10MG BASE/ML N62008 004 Jun DISC
>D> AP + EQ 10MG BASE/ML N50477 005 Jun DISC
>A> @ EQ 10MG BASE/ML N50477 005 Jun DISC
>D> AP + EQ 40MG BASE/ML N62008 001 Jun DISC
>A> @ EQ 40MG BASE/ML N62008 001 Jun DISC
>D> AP + EQ 1.2GM BASE/VIAL N50519 001 Jun DISC
>A> @ EQ 1.2GM BASE/VIAL N50519 001 Jun DISC
TOBRAMYCIN
>D> AP PHARMA TEK EQ 1.2GM BASE/VIAL N65013 001 Aug 17, 2001 Jun CRLD
>A> AP + EQ 1.2GM BASE/VIAL N65013 001 Aug 17, 2001 Jun CRLD
TOBRAMYCIN SULFATE
>D> AP HOSPIRA EQ 10MG BASE/ML N63080 001 Apr 30, 1991 Jun CRLD
>A> AP + EQ 10MG BASE/ML N63080 001 Apr 30, 1991 Jun CRLD
TOPIRAMATE
TABLET; ORAL
TOPAMAX
>D> @ ORTHO MCNEIL PHARM 50MG N20505 005 Dec 24, 1996 Jun CMFD
>A> 50MG N20505 005 Dec 24, 1996 Jun CMFD
TRIAMCINOLONE
TABLET; ORAL
ARISTOCORT
>D> BP FUJISAWA 4MG N11161 007 Jun CRLD
>A> BP + 4MG N11161 007 Jun CRLD
>D> KENACORT
>D> + BRISTOL MYERS 8MG N11283 010 Jun DISC
>A> @ 8MG N11283 010 Jun DISC
>D> TRIAMCINOLONE
>D> BP WATSON LABS 4MG N84270 001 Jun DISC
>A> @ 4MG N84270 001 Jun DISC
>D> TRIAMCINOLONE DIACETATE
>D> INJECTABLE; INJECTION
>D> ARISTOCORT
>D> + SABEX 2002 25MG/ML N11685 003 Jun DISC
>A> @ 25MG/ML N11685 003 Jun DISC
>D> + 40MG/ML N12802 001 Jun DISC
>A> @ 40MG/ML N12802 001 Jun DISC
TRIMIPRAMINE MALEATE
CAPSULE; ORAL
SURMONTIL
>A> ODYSSEY PHARMS EQ 25MG BASE N16792 001 Jun CAHN
>A> EQ 50MG BASE N16792 002 Jun CAHN
>A> + EQ 100MG BASE N16792 003 Sep 15, 1982 Jun CAHN
>D> PLIVA EQ 25MG BASE N16792 001 Jun CAHN
>D> PLIVA EQ 50MG BASE N16792 002 Jun CAHN
>D> + EQ 100MG BASE N16792 003 Sep 15, 1982 Jun CAHN
>D> TROVAFLOXACIN MESYLATE
>D> TABLET; ORAL
>D> TROVAN
>D> PFIZER EQ 100MG BASE N20759 001 Dec 18, 1997 Jun DISC
>A> @ EQ 100MG BASE N20759 001 Dec 18, 1997 Jun DISC
>D> + EQ 200MG BASE N20759 002 Dec 18, 1997 Jun DISC
>A> @ EQ 200MG BASE N20759 002 Dec 18, 1997 Jun DISC
TUBOCURARINE CHLORIDE
INJECTABLE; INJECTION
TUBOCURARINE CHLORIDE
>D> AP + BRISTOL MYERS 3MG/ML N05657 001 Jun CTEC
>A> + 3MG/ML N05657 001 Jun CTEC
>D> AP + HOSPIRA 3MG/ML N06095 001 Jun DISC
>A> @ 3MG/ML N06095 001 Jun DISC
VANCOMYCIN HYDROCHLORIDE
>D> FOR SOLUTION; ORAL
>D> VANCOCIN HCL
>D> + LILLY EQ 250MG BASE/5ML N61667 002 Jul 13, 1983 Jun DISC
>A> @ EQ 250MG BASE/5ML N61667 002 Jul 13, 1983 Jun DISC
>D> + EQ 500MG BASE/6ML N61667 001 Jun DISC
>A> @ EQ 500MG BASE/6ML N61667 001 Jun DISC
INJECTABLE; INJECTION
VANCOCIN HCL
>D> AP LILLY EQ 500MG BASE/VIAL N62812 001 Nov 17, 1987 Jun DISC
>A> @ EQ 500MG BASE/VIAL N62812 001 Nov 17, 1987 Jun DISC
>D> AP EQ 500MG BASE/VIAL N62716 001 Mar 13, 1987 Jun DISC
>A> @ EQ 500MG BASE/VIAL N62716 001 Mar 13, 1987 Jun DISC
>D> AP EQ 500MG BASE/VIAL N62476 001 Mar 15, 1984 Jun DISC
>A> @ EQ 500MG BASE/VIAL N62476 001 Mar 15, 1984 Jun DISC
>D> AP + EQ 500MG BASE/VIAL N60180 001 Jun DISC
>A> @ EQ 500MG BASE/VIAL N60180 001 Jun DISC
>D> AP EQ 1GM BASE/VIAL N62812 002 Nov 17, 1987 Jun DISC
>A> @ EQ 1GM BASE/VIAL N62812 002 Nov 17, 1987 Jun DISC
>D> AP EQ 1GM BASE/VIAL N62716 002 Mar 13, 1987 Jun DISC
>A> @ EQ 1GM BASE/VIAL N62716 002 Mar 13, 1987 Jun DISC
>D> AP EQ 1GM BASE/VIAL N62476 002 Mar 21, 1986 Jun DISC
>A> @ EQ 1GM BASE/VIAL N62476 002 Mar 21, 1986 Jun DISC
>D> AP + EQ 1GM BASE/VIAL N60180 002 Mar 21, 1986 Jun DISC
>A> @ EQ 1GM BASE/VIAL N60180 002 Mar 21, 1986 Jun DISC
>D> AP + EQ 10GM BASE/VIAL N62812 003 Nov 17, 1987 Jun DISC
>A> @ EQ 10GM BASE/VIAL N62812 003 Nov 17, 1987 Jun DISC
BUTOCONAZOLE NITRATE
CREAM; VAGINAL
FEMSTAT 3
>A> + BAYER 2% N20421 001 Dec 21, 1995 Jun CAHN
>D> + ROCHE PALO 2% N20421 001 Dec 21, 1995 Jun CAHN
>D> CHLORHEXIDINE GLUCONATE
>D> SOLUTION; TOPICAL
>D> CHLORAPREP ONE-STEP
>D> + BECKLOFF 2% N21555 001 Oct 07, 2002 Jun CAIN
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SPONGE; TOPICAL
>D> CHLORAPREP
>D> + MEDI FLEX HOSP 2%;70% N20832 001 Jul 14, 2000 Jun CTNA
>A> CHLORAPREP ONE-STEP FREPP
>A> + MEDI FLEX HOSP 2%;70% N20832 001 Jul 14, 2000 Jun CTNA
>A> SWAB; TOPICAL
>A> CHLORAPREP ONE-STEP SEPP
>A> + MEDI FLEX HOSP 2%;70% N21555 001 Oct 07, 2002 Jun CAIN
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> MUCINEX D
>A> ADAMS 600MG;60MG N21585 001 Jun 22, 2004 Jun NEWA
>A> + 1.2GM;120MG N21585 002 Jun 22, 2004 Jun NEWA
IBUPROFEN
TABLET; ORAL
IBUPROFEN
>A> LNK 100MG N76741 001 Jun 17, 2004 Jun NEWA
LORATADINE
TABLET; ORAL
LORATADINE
>A> PERRIGO 10MG N76301 001 Jun 25, 2004 Jun NEWA
>A> 10MG N21512 001 Jun 24, 2004 Jun NEWA
none.
 Back
to Top 
Index Page
Date Created: July 27, 2004 |
|
